Literature DB >> 24831436

The schizophrenia/bipolar disorder candidate gene GNB1L is regulated in human temporal cortex by a cis-acting element located within the 3'-region.

Yue Sun1, Yu Tao, Jian Wang, David Saffen.   

Abstract

22q11.2 deletion syndrome (DS) is a complex developmental disorder with a high incidence of psychiatric illnesses, including schizophrenia and mood disorders. Recent studies have identified Guanine Nucleotide Binding Protein (G protein) Beta Polypeptide 1-Like (GNB1L), located within the 1.5 Mbp 22q11.2 DS critical region, as a candidate liability gene for schizophrenia and bipolar disorder. In this study, we used mRNA expression measurements in Han Chinese postmortem temporal cortex and linkage disequilibrium (LD) analysis to show that GNB1L is regulated by a cis-acting genetic variant within the 3'-region of the gene. Significantly, this variant is located within an LD block that contains all of the common SNPs previously shown to associate with schizophrenia and bipolar disorder in Han Chinese and Caucasian populations. Contrary to our expectations, re-analysis of previously published case-control study data in light of our mRNA expression results implies that the GNB1L high-expression allele is the risk allele for schizophrenia and bipolar disorder in the Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24831436      PMCID: PMC5562634          DOI: 10.1007/s12264-014-1461-0

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  30 in total

Review 1.  Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan
Journal:  Medicine (Baltimore)       Date:  2011-01       Impact factor: 1.889

2.  Der(22) syndrome and velo-cardio-facial syndrome/DiGeorge syndrome share a 1.5-Mb region of overlap on chromosome 22q11.

Authors:  B Funke; L Edelmann; N McCain; R K Pandita; J Ferreira; S Merscher; M Zohouri; L Cannizzaro; A Shanske; B E Morrow
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

Review 3.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

4.  Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder?

Authors:  D F Papolos; G L Faedda; S Veit; R Goldberg; B Morrow; R Kucherlapati; R J Shprintzen
Journal:  Am J Psychiatry       Date:  1996-12       Impact factor: 18.112

5.  Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain.

Authors:  J Raphael Gibbs; Marcel P van der Brug; Dena G Hernandez; Bryan J Traynor; Michael A Nalls; Shiao-Lin Lai; Sampath Arepalli; Allissa Dillman; Ian P Rafferty; Juan Troncoso; Robert Johnson; H Ronald Zielke; Luigi Ferrucci; Dan L Longo; Mark R Cookson; Andrew B Singleton
Journal:  PLoS Genet       Date:  2010-05-13       Impact factor: 5.917

6.  Strong evidence that GNB1L is associated with schizophrenia.

Authors:  Nigel M Williams; Beate Glaser; Nadine Norton; Hywel Williams; Timothy Pierce; Valentina Moskvina; Stephen Monks; Jurgen Del Favero; Dirk Goossens; Dan Rujescu; Ina Giegling; George Kirov; Nicholas Craddock; Kieran C Murphy; Michael C O'Donovan; Michael J Owen
Journal:  Hum Mol Genet       Date:  2007-11-13       Impact factor: 6.150

Review 7.  Velo-cardio-facial syndrome: 30 Years of study.

Authors:  Robert J Shprintzen
Journal:  Dev Disabil Res Rev       Date:  2008

8.  Supportive evidence for reduced expression of GNB1L in schizophrenia.

Authors:  Hiroki Ishiguro; Minori Koga; Yasue Horiuchi; Emiko Noguchi; Miyuki Morikawa; Yoshimi Suzuki; Makoto Arai; Kazuhiro Niizato; Shyuji Iritani; Masanari Itokawa; Toshiya Inada; Nakao Iwata; Norio Ozaki; Hiroshi Ujike; Hiroshi Kunugi; Tsukasa Sasaki; Makoto Takahashi; Yuichiro Watanabe; Toshiyuki Someya; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyuki Nawa; Tadao Arinami
Journal:  Schizophr Bull       Date:  2008-11-14       Impact factor: 9.306

9.  A comprehensive analysis of 22q11 gene expression in the developing and adult brain.

Authors:  T M Maynard; G T Haskell; A Z Peters; L Sikich; J A Lieberman; A-S LaMantia
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-12       Impact factor: 11.205

10.  Next-generation DNA sequencing-based assay for measuring allelic expression imbalance (AEI) of candidate neuropsychiatric disorder genes in human brain.

Authors:  Xiang Xu; Hao Wang; Min Zhu; Yue Sun; Yu Tao; Qin He; Jian Wang; Li Chen; David Saffen
Journal:  BMC Genomics       Date:  2011-10-20       Impact factor: 3.969

View more
  1 in total

1.  An update on research and approaches in biological psychiatry.

Authors:  Lingjiang Li
Journal:  Neurosci Bull       Date:  2015-02       Impact factor: 5.203

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.